Ironwood Pharmaceuticals Inc. (IRWD) announced after the bell Monday that it has commenced an underwritten public offering of 10,500,000 shares of its Class A common stock. The stock is now down 0.58 on 27K shares.
Ironwood Pharmaceuticals declined during the first half hour of trade Monday and finished with a loss of 0.56 at $13.83 on above average volume. The stock fell to a 3-month low.
For comments and feedback: editorial@rttnews.com